Rothia mucilaginosa Infections in Pediatric Cancer Patients

Abstract
We performed a retrospective study to determine the epidemiology of Rothia mucilaginosa infections among pediatric cancer patients. Over 20 years, 37 cases were identified; 27% developed complications, but there was no infection-related mortality. All cases were successfully treated with vancomycin.
Funding Information
  • National Institutes of Health
  • St Jude Pediatric Oncology Education Program and American Lebanese Syrian Associated Charities